chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: soreness and redness where given the injection; soreness and redness where given the injection; Fever; Headache; Chills; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262, expiry date not reported), via an unspecified route of administration at the left arm on 20Jan2021 17:30 at single dose for COVID-19 immunization. Medical history included high blood pressure, high cholesterol, thyroid disorder and COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications (unspecified) in two weeks were given. On 21Jan2021 15:00, the patient experienced soreness and redness where given the injection, fever, headache, and chills. No treatment was received for the adverse events. Clinical outcome of the events was recovering.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Rash
Clinical narrative: Headache; muscle cramps; rash; This is a spontaneous report from a contactable other hcp (patient).  This 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot # unknown), via an unspecified route of administration at single dose in the left arm on 13Jan2021 for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), venlafaxine hydrochloride (EFFEXOR). The patient previously took Keflex [cefalexin] and experienced drug allergy. On 13Jan2021, the patient experienced headache, muscle cramps, rash, all with outcome of recovering. No treatment required. The vaccine was administered at Hospital Facility. The patient had not been tested for COVID-19 post the vaccination. The patient was not pregnant at the time of vaccination.  Information on the lot/batch number has been requested.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Neck pain, Sinus headache
Clinical narrative: severe sinus like headaches come on in evening with severe neck pain.; hard to sleep; severe sinus like headaches come on in evening with severe neck pain.; This is a spontaneous report from a contactable consumer. An 80-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 10:30 at single dose (Lot # EL8982, EXP-20May2021) for covid-19 immunisation Medical history included Osteoporosis of spine, left thyroid removed, acid reflux. Known allergies: penicillin, latex. No other vaccine in four weeks. No COVID prior vaccination. Concomitant medication included levothyroxine sodium (SYNTHROID), lisinopril, colecalciferol (VIT D3), omeprazole. The patient experienced after 2nd day severe sinus like headaches come on in evening with severe neck pain. Have had this for 4 nights, hard to sleep. Events start date: 20Jan2021 08:00 PM. Treatment included Advil (cold and sinus) every day to help. It did help, but did not like to take this type of medicine that often. No COVID tested post vaccination. Outcome of events was not recovered.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Neck pain, Sinus headache
Clinical narrative: Terrible sinus headache; Neck pain; She did not sleep for four nights; This is a spontaneous report from a contactable consumer (patient).   An 80 years old female patient received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Lot. EL8982, Expiration date: 20May2021) at single dose, on 19Jan2021, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. On 20Jan2021, the day after the vaccination, the patient experienced a terrible sinus headache, neck pain and did not sleep for four nights. The patient reported that she was on a very strict diet with no sugar and she didn't know if it was from her diet or if this is a side effect. She had done yoga for 22 years and she tried to do some yoga and it relived it a little bit. The patient was treated with Advil. Clinical outcome of the events was unknown at time of this report. Second dose was scheduled for 09Feb2021.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Flushing, Pain, Rash papular
Clinical narrative: Raised rash on face; Raised rash on face and injection site; flushed feeling face; chills; Body aches; brain fog/ overall not up to feeling like myself; This is a spontaneous report from a contactable nurse reported for herself. A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on the right arm on 22Jan2021 15:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing and cerebrovascular accident from an unknown date and unknown if ongoing. The patient previously took morphine and experienced drug hypersensitivity. On 23Jan2021 10:30, the patient experienced raised rash on face and injection site, flushed feeling face, chills, overall not up to feeling like myself, body aches and brain fog. No treatment was received for the events. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Raised rash on face; Raised rash on face and injection site; flushed feeling face; chills; Body aches; brain fog/ overall not up to feeling like myself; This is a spontaneous report from a contactable nurse reported for herself. A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on the right arm on 22Jan2021 15:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing and cerebrovascular accident from an unknown date and unknown if ongoing. The patient previously took morphine and experienced drug hypersensitivity. On 23Jan2021 10:30, the patient experienced raised rash on face and injection site, flushed feeling face, chills, overall not up to feeling like myself, body aches and brain fog. No treatment was received for the events. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Headache, Hypoaesthesia, Myalgia
Clinical narrative: Headache; neck pain; numbness into extremities; extreme pain in left arm; Extreme muscle pain in neck caused me to go to ER; Significant bilateral shoulder pain; Weakness; This is a spontaneous report from a contactable consumer (patient). This 36-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration on 20Jan2021 16:45 at a single dose on the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient is not pregnant at the time of report and at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient has no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose on 31Dec2020 on the left arm. On 20Jan2021 21:00, the patient's extreme muscle pain in neck caused her to go to the ER and tramadol and Norflex were administered. The patient had significant bilateral shoulder pain and weakness. The head and muscle pain in neck persisted. Events resulted in emergency room/department or urgent care. Treatment received were tramadol and Norflex. On 20Jan2021 22:00, the patient experienced headache, neck pain, numbness into extremities, and extreme pain in left arm. The events resulted in emergency room/department or urgent care. Tramadol was received as treatment but it worsened the symptoms. The tramadol was administered on the left arm at the hospital. Outcome of the events "extreme muscle pain in neck", "significant bilateral shoulder pain", and "weakness" was unknown and of the other events was not recovered.  Information about lot/batch number has been requested.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site pain
Clinical narrative: Headache; neck pain; numbness into extremities; extreme pain in left arm; Extreme muscle pain in neck caused me to go to ER; Significant bilateral shoulder pain; Weakness; This is a spontaneous report from a contactable consumer (patient). This 36-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration on 20Jan2021 16:45 at a single dose on the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient is not pregnant at the time of report and at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient has no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose on 31Dec2020 on the left arm. On 20Jan2021 21:00, the patient's extreme muscle pain in neck caused her to go to the ER and tramadol and Norflex were administered. The patient had significant bilateral shoulder pain and weakness. The head and muscle pain in neck persisted. Events resulted in emergency room/department or urgent care. Treatment received were tramadol and Norflex. On 20Jan2021 22:00, the patient experienced headache, neck pain, numbness into extremities, and extreme pain in left arm. The events resulted in emergency room/department or urgent care. Tramadol was received as treatment but it worsened the symptoms. The tramadol was administered on the left arm at the hospital. Outcome of the events "extreme muscle pain in neck", "significant bilateral shoulder pain", and "weakness" was unknown and of the other events was not recovered.  Information about lot/batch number has been requested.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Palpitations, Vomiting
Clinical narrative: Chills; heart racing; Vomiting; This is a spontaneous report from a contactable healthcare professional (patient). A 26-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration in the left arm on 23Jan2021 15:15 at single dose for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. No known allergies. The patient is not pregnant. No other vaccine in four weeks and no other medications in two weeks. The patient had no COVID prior vaccination and not tested with COVID test post vaccination. The patient experienced chills, heart racing, and vomiting, 4 hours after vaccination on 23Jan2021 19:15. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Heart rate, Heart rate increased
Clinical narrative: Heaviness in chest; Racing heartbeat; Fatigue; This is a spontaneous report from a contactable other hcp (patient). The 41-years-old female patient (not pregnant) received bnt162b2 (BNT162B2), via an unspecified route of administration on 13Jan2021 10:15 in Left arm at single dose for covid-19 immunisation. Medical history included none. No other vaccine in four weeks, no other medications in two weeks, increased protein. No covid prior vaccination. No covid tested post vaccination. No Known allergies. The patient's concomitant medications were not reported. The patient experienced Heaviness in chest, racing heartbeat, fatigue on 22Jan2021. No treatment received. The outcome of the events was not recovered.  No follow-up attempts are possible, information on batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Ear pain, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Fever; chills; runny nose; ear ache; body aches; swollen glands; This is a spontaneous report from a contactable Other HCP (patient). This 27-Year-old female Other HCP patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number El3248/expiration date: unknown), via unknown route of administration, on 22Jan2021 01:45 PM (at the age of 27 years old) as a single dose on left arm for COVID-19 immunisation at a hospital. Relevant medical history included Depression, insomnia. The patient had no known allergies. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number Ek9231/expiration date: unknown), via unknown route of administration, on 04Jan2021 01:00 PM (at the age of 27 years old) as a single dose on left arm for COVID-19 immunisation. The patient was not pregnant at time of vaccination. Relevant concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that on 23Jan2021 01:00 AM, the patient experienced fever, chills, runny nose, ear ache, body aches, swollen glands. The outcome of the events fever, chills, runny nose, ear ache, body aches, swollen glands was not recovered. No treatment was received for the events. Since the vaccination, the patient has not been tested for COVID-19.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Fever; chills; runny nose; ear ache; body aches; swollen glands; This is a spontaneous report from a contactable Other HCP (patient). This 27-Year-old female Other HCP patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number El3248/expiration date: unknown), via unknown route of administration, on 22Jan2021 01:45 PM (at the age of 27 years old) as a single dose on left arm for COVID-19 immunisation at a hospital. Relevant medical history included Depression, insomnia. The patient had no known allergies. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number Ek9231/expiration date: unknown), via unknown route of administration, on 04Jan2021 01:00 PM (at the age of 27 years old) as a single dose on left arm for COVID-19 immunisation. The patient was not pregnant at time of vaccination. Relevant concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that on 23Jan2021 01:00 AM, the patient experienced fever, chills, runny nose, ear ache, body aches, swollen glands. The outcome of the events fever, chills, runny nose, ear ache, body aches, swollen glands was not recovered. No treatment was received for the events. Since the vaccination, the patient has not been tested for COVID-19.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain, SARS-CoV-2 test
Clinical narrative: Burning pain internally for over a week; weakness on the left arm; This is a spontaneous report from a contactable Nurse (patient). A 44-years-old female patient received second dose of  bnt162b2 (BNT162B2), intramuscular on 15Jan2021 08:00 at SINGLE DOSE for covid-19 immunisation. Medical history and concomitant medications was none. Historical vaccine at 44 year old included product=COVID 19, brand=Pfizer, lot unknown=False, administration date=25Dec2020, administration time=08:45 AM, vaccine location=Left arm, dose number=1} for covid-19 immunisation. No Known allergies. No covid prior vaccination. No other vaccine in four weeks. The patient experienced burning pain internally for over a week, weakness on the left arm on 15Jan2021 09:00 with outcome of not recovered. Still on pain 10/10 throbbing pain Tylenol, ibuprofen, ice packs, heating pad have not reduced the pain. The patient underwent lab tests and procedures which included pain: 10/10 on 15Jan2021, Covid test post vaccination: covid test type post vaccination=Nasal Swab: negative on 22Jan2021.   Information on the Lot/Batch number has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: Left chest pain; Difficulty breathing; This is a spontaneous report from a contactable other healthcare professional (patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), intramuscular (right arm) on 22Jan2021 (15:30 )at single dose for Covid-19 immunization. There was no medical history. Concomitant medications included Flu shot (reported as other vaccine in 4 weeks) 1 dose on 08Jan2021.The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. On 24Jan2021 (12:00 PM), the patient experienced left chest pain and difficulty breathing. There was no treatment received for the adverse events. The patient has not been tested for COVID-19 since the vaccination. The outcome of events was unknown.  Information about lot/batch no has been requested.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Malaise
Clinical narrative: Injection site pain; Tiredness; Headache; Chills; Nausea; vomiting; Feeling unwell; Diarrhea; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL9262, expiration date unspecified), via an unspecified route of administration on 23Jan2021 13:45 at single dose (left arm) for COVID-19 immunization. The patient had no medical history. The patient was not pregnant and had no known allergies. The patient's concomitant medications were not reported. On 23Jan2021 22:00, the patient experienced injection site pain, tiredness, headache, chills, nausea, vomiting, feeling unwell and diarrhea. There was no therapy for the events. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient did not have Covid prior vaccination and was not Covid tested post vaccination. Outcome of the events was not recovered.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain, Vomiting
Clinical narrative: Injection site pain; Tiredness; Headache; Chills; Nausea; vomiting; Feeling unwell; Diarrhea; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL9262, expiration date unspecified), via an unspecified route of administration on 23Jan2021 13:45 at single dose (left arm) for COVID-19 immunization. The patient had no medical history. The patient was not pregnant and had no known allergies. The patient's concomitant medications were not reported. On 23Jan2021 22:00, the patient experienced injection site pain, tiredness, headache, chills, nausea, vomiting, feeling unwell and diarrhea. There was no therapy for the events. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient did not have Covid prior vaccination and was not Covid tested post vaccination. Outcome of the events was not recovered.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age started received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced sore arm on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: the patient has been waking up with a stiff neck which was worse at night; This is a spontaneous report from a medical team. A contactable consumer (patient himself) reported that a male patient of an unspecified age (Age:70; Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at SINGLE DOSE (first dose) for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Over the past two days (unspecified dates), the patient has been waking up with a stiff neck which was worse at night. The outcome of event was unknown.  Follow-up attempts are completed. The following information on the batch number has been requested.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: local pain at the vaccine location; Tiredness/fatigue; This is a spontaneous report from a contactable consumer (patient).  A 66-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, lot/batch number: EL9262) , via an unspecified route of administration on the right arm on 20Jan2021 17:15 at SINGLE DOSE for COVID-19 immunization.  Medical history included blood pressure abnormal (reported as BP).  Concomitant medication included amlodipine (AMLODIPINE) for unknown indication and unspecified BP medication. On 21Jan2021 06:00, the patient experienced local pain at the vaccine location and tiredness/fatigue and recovered in Jan2021.  The patient did not receive treatment for the event.  The patient was not diagnosed with COVID-19 prior and not tested since vaccination.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: I had a light presentation of hives. The locations of the hives were in the crease of my right arm (elbow area), torso (tummy area), top of foot and ankles.; This is a spontaneous report from a contactable consumer (patient).  A 63-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, lot/batch number: ELI283), via an unspecified route of administration on the left arm on 23Jan2021 11:45 at SINGLE DOSE for COVID-19 immunization. It was reported that the patient was allergic to Amoxicillin. The patient was not pregnant (including at the time of vaccination). Medical history and concomitant medications were not reported. On 23Jan2021 22:00, the patient had a light presentation of hives.  The locations of the hives were in the crease of the right arm (elbow area), torso (tummy area), top of foot and ankles. The patient did not receive treatment for the event.  The patient was not diagnosed with COVID-19 prior and not tested since vaccination. Outcome of the event was recovering.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Fatigue, Nasal congestion, Nasopharyngitis, Pain
Clinical narrative: Head and nasal congestion; Head and nasal congestion; ear ache; body aches; fatigue; sore arm; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283), via an unspecified route of administration on 22Jan2021,16:30 at SINGLE DOSE (first dose, left arm) for COVID-19 immunization. Medical history included allergies: Latex from an unspecified date. Patient did not have COVID-19 prior vaccination. Patient is not pregnant. No other vaccine in four weeks. The patient's concomitant medications were not reported. The patient experienced head and nasal congestion, ear ache, body aches, fatigue and, sore arm all on 23Jan2021 01:00. No treatment was given. Patient was not tested for COVID-19 post vaccination. Outcome of the events was recovering.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Head and nasal congestion; Head and nasal congestion; ear ache; body aches; fatigue; sore arm; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283), via an unspecified route of administration on 22Jan2021,16:30 at SINGLE DOSE (first dose, left arm) for COVID-19 immunization. Medical history included allergies: Latex from an unspecified date. Patient did not have COVID-19 prior vaccination. Patient is not pregnant. No other vaccine in four weeks. The patient's concomitant medications were not reported. The patient experienced head and nasal congestion, ear ache, body aches, fatigue and, sore arm all on 23Jan2021 01:00. No treatment was given. Patient was not tested for COVID-19 post vaccination. Outcome of the events was recovering.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenopia, Blepharospasm
Clinical narrative: left eye keeps twitching; No immediate vision changes until later in the day when left eye gets tired; This is a spontaneous report from a contactable nurse (patient) reported that a 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on the right arm on 24Dec2020 07:45 at a single dose for Covid-19 immunization. The vaccine was administered at the hospital. The patient's medical history and concomitant medications were not reported. Patient is not pregnant. On 26Dec2020 (also reported as 'approximately 2 days after the first vaccination'), the patient's left eye keeps twitching. No pain. May intensify and becomes obvious. No immediate vision changes until later in the day when left eye gets tired. No treatment received for the reported events. The outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Vaccination site mass, Vaccination site pain
Clinical narrative: vomited; chills; headache; had some itching, ongoing soreness and lump at site; had some itching, ongoing soreness and lump at site; had some itching, ongoing soreness and lump at site; nauseous; This is a spontaneous report from a contactable consumer (patient).  A 65-year-old female patient received the first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Lot number: EL9262), via an unspecified route of administration in the left arm on 22Jan2021 19:00 at a single dose for COVID-19 immunization. She takes thyroid daily (as reported) as it was removed when she was 20.  The patient was not pregnant at the time of vaccination. The patient had no COVID prior to vaccination. The patient had not been tested for COVID post vaccination. The patient has not received any vaccine in 4 weeks. Concomitant medication included teriparatide (FORTEO) daily injection, diphenhydramine hydrochloride (BENADRYL). The patient previously took codeine and experienced allergies: codeine. The patient reported that no one knew if she should inject with teriparatide. On 22Jan2021, she received teriparatide at 4pm and bnt162b2 at 7pm. She took a diphenhydramine and had some itching, ongoing soreness and lump at site. She took teriparatide at 3:30pm at about 7pm she was nauseous and vomited. She had chills but felt better afterwards. She went to bed and have headache, not sure if she should discontinue teriparatide or discontinue before next shot. According to the reporter, the events started on 23Jan2021 19:00; vomited started on 23Jan2021 21:00. The outcome of the event was recovering.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vomiting
Clinical narrative: vomited; chills; headache; had some itching, ongoing soreness and lump at site; had some itching, ongoing soreness and lump at site; had some itching, ongoing soreness and lump at site; nauseous; This is a spontaneous report from a contactable consumer (patient).  A 65-year-old female patient received the first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Lot number: EL9262), via an unspecified route of administration in the left arm on 22Jan2021 19:00 at a single dose for COVID-19 immunization. She takes thyroid daily (as reported) as it was removed when she was 20.  The patient was not pregnant at the time of vaccination. The patient had no COVID prior to vaccination. The patient had not been tested for COVID post vaccination. The patient has not received any vaccine in 4 weeks. Concomitant medication included teriparatide (FORTEO) daily injection, diphenhydramine hydrochloride (BENADRYL). The patient previously took codeine and experienced allergies: codeine. The patient reported that no one knew if she should inject with teriparatide. On 22Jan2021, she received teriparatide at 4pm and bnt162b2 at 7pm. She took a diphenhydramine and had some itching, ongoing soreness and lump at site. She took teriparatide at 3:30pm at about 7pm she was nauseous and vomited. She had chills but felt better afterwards. She went to bed and have headache, not sure if she should discontinue teriparatide or discontinue before next shot. According to the reporter, the events started on 23Jan2021 19:00; vomited started on 23Jan2021 21:00. The outcome of the event was recovering.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Malaise, Vaccination site pain
Clinical narrative: Very bad arm pain on injection arm; tiredness; mild headache; chills; feeling unwell; This is a spontaneous report from a contactable consumer (patient herself).  A 67-year-old female patient received bnt162b2 (BNT162B2 also reported as COVID 19 vaccine, lot/batch number and expiry date were not reported), via an unspecified route of administration in arm on 16Jan2021 10:30 at SINGLE DOSE for Covid-19 immunisation. Medical history included allergy to latex, iodine, motrin. No other vaccine in four weeks. There were no concomitant medications. On 16Jan2021 15:00, the patient experienced very bad arm pain on injection arm, tiredness, mild headache, chills, feeling unwell overall for 4 solid days. No treatment was given. The outcome of events was recovered on 20Jan2021.  Information about lot and batch number was requested.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Pyrexia
Clinical narrative: fever; persistent cough; This is a spontaneous report from a contactable consumer (patient herself). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration in the left arm on 22Jan2021 15:00 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient had no known allergies and was not pregnant. She had not been diagnosed with COVID prior to vaccination. Concomitant medications included metformin 500 mg and hydrochlorothiazide 12.5 mg. The patient experienced fever a persistent cough and fever on 22Jan2021 19:00. No treatment was received for the events. The outcome of the events was recovering. The patient was not tested for COVID post vaccination.    Information on the lot/batch number has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Nausea, Paraesthesia
Clinical narrative: Fatigue; headache; weakness; nausea; tingling on right side of body; This is a spontaneous report from a contactable other health professional (patient). A 47-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration (right arm) on 22Jan2021 17:30 at single dose for Covid-19 immunization. The patient's medical history was not reported. Concomitant medication included lisinopril from an unspecified date for an unspecified indication.  The patient previously took Codeine and Compazine and experienced allergy. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Jan2021 (13:00), the patient experienced fatigue, headache, weakness, nausea, and tingling on right side of body. There was no treatment received for the adverse event. The outcome of events was recovering. The patient has not been tested for COVID-19 since the vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Ear pain, Eustachian tube disorder, Productive cough, Vertigo
Clinical narrative: right ear began to hurt; eustachian tube inflammation; slight vertigo; metallic taste in mouth; phlegm drainage in throat; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration (left arm) on 20Jan2021 (15:00) at single dose for Covid-19 immunization. Medical history included penicillin allergy (Known allergies: penicillin, ciprofloxin, levofloxacin, hylan G-F, lexapro, bacitracin). Concomitant medication included potassium chloride. The patient previously took Ciprofloxin, Levofloxacin, Hylan G-F, Lexapro, and Bacitracin and experienced allergy. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Jan2021 (10:00), the patient began to experience slight vertigo accompanied by metallic taste in mouth and phlegm drainage in throat (reported as "phlym"). When she laid down in bed at right side mainly her vertigo got worse. Late Saturday afternoon (23Jan2021), her right ear began to hurt. She went to urgent care at 7:30 pm. The doctor prescribed vertigo exercises, Flonase nasal spray for possible eustachian tube inflammation and ibuprophin. On Sunday (24Jan2021: today), the patient was still experiencing pretty severe vertigo; not much improved. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient had vertigo exercises, ibuprophin, and Flonase spray as treatment. The outcome of events was not recovered. The patient has not been tested for COVID-19 since the vaccination.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Heart rate, Palpitations, Rhesus antibodies
Clinical narrative: headache; heart-pounding, racing heart beat,; dizziness; feelings of passing out; This is a spontaneous report from a contactable consumer. A 66-year-old non-pregnant female received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL9262), via an unspecified route of administration in the left arm on 23Jan2021 10:00, at 0.3ml, single for covid-19 immunization.The patient medical history was not reported. Patient is an Rh Neg A blood type and did not have Covid, as she's been isolated for a year.  Concomitant medication included gabapentin, paroxetine hydrochloride and atorvastatin. On 23Ja2021, after half an hour (10:30) of receiving 1st dose of the vaccine, patient experienced heart pounding, racing heart beat, dizziness, feelings of passing out. These symptoms lasted up to 3 hours. Patient sat her my car outside of the an emergency parking lot for 3 hours because she couldn't drive home during these symptoms. Patient was on the verge of going into emergency care. For the remainder of the day, patient's sitting heart beat was at 90. The next day, 24Jan201, she felt better but have on and off slight headache. She did not plan on taking the 2nd dose. The outcome of the events was recovering. The patient has not tested positive for Covid-19 post vaccination.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Lymphadenopathy, Migraine
Clinical narrative: Chill; fever; body aches; migraine; dizziness; soreness at injection site; headache; lymph node swollen on left arm pit area; This is a spontaneous report from a contactable other healthcare professional(patient). A 47-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: El3302), intramuscularly into the left arm on 23Jan2021 11:45 at a single dose for covid-19 immunisation. Medical history was reported as none. Patient was not pregnant. Concomitant medication included escitalopram oxalate (LEXAPRO), riboflavin (RIBOFLAVIN), multivitamins and antihistamine (unspecified). The patient was previously administered with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: El0140), intramuscularly into the left arm on 02Jan2021 12:30 at a single dose for covid-19 immunization. On 23Jan2021 20:30, patient experienced chill, fever, body aches, migraine and dizziness. On 23Jan2021, patient experienced soreness at injection site, headache and lymph node swollen on the left armpit area. The patient did not receive treatment for the events reported. Outcome of events were recovering.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site pain
Clinical narrative: Chill; fever; body aches; migraine; dizziness; soreness at injection site; headache; lymph node swollen on left arm pit area; This is a spontaneous report from a contactable other healthcare professional(patient). A 47-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: El3302), intramuscularly into the left arm on 23Jan2021 11:45 at a single dose for covid-19 immunisation. Medical history was reported as none. Patient was not pregnant. Concomitant medication included escitalopram oxalate (LEXAPRO), riboflavin (RIBOFLAVIN), multivitamins and antihistamine (unspecified). The patient was previously administered with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: El0140), intramuscularly into the left arm on 02Jan2021 12:30 at a single dose for covid-19 immunization. On 23Jan2021 20:30, patient experienced chill, fever, body aches, migraine and dizziness. On 23Jan2021, patient experienced soreness at injection site, headache and lymph node swollen on the left armpit area. The patient did not receive treatment for the events reported. Outcome of events were recovering.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Gait disturbance, Headache, Joint range of motion decreased
Clinical narrative: Pain through back across both arms and neck.; A headache that feels like my heads going to explode.; swell up like a balloon; Nauseated; Chills; fever; Pain on both my legs cannot walk; Pain through back across both arms and neck. Cannot lift my arms; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on the right arm on 20Jan2021 16:00 at single dose for covid-19 immunization.  Medical history included atrial fibrillation from an unknown date and unknown if ongoing , hypersensitivity (Known allergies: Yes) from an unknown date and unknown if ongoing, covid-19 (if covid prior vaccination: Yes) from an unknown date and unknown if ongoing. Concomitant medications included unspecified medications. The patient experienced pain through back across both arms and neck, the patient cannot lift their arms. The patient also experienced pain on both their legs cannot walk, a headache that feels like their heads going to explode, nauseated all the time, swell up like a balloon, chills and fever. It was reported that the events occurred on 21Jan2021. Therapeutic measures were taken as a result of pain through back across both arms and neck. The patient did not recover from the events.  Information on the lot/batch number has been requested.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Nausea, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: Pain through back across both arms and neck.; A headache that feels like my heads going to explode.; swell up like a balloon; Nauseated; Chills; fever; Pain on both my legs cannot walk; Pain through back across both arms and neck. Cannot lift my arms; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on the right arm on 20Jan2021 16:00 at single dose for covid-19 immunization.  Medical history included atrial fibrillation from an unknown date and unknown if ongoing , hypersensitivity (Known allergies: Yes) from an unknown date and unknown if ongoing, covid-19 (if covid prior vaccination: Yes) from an unknown date and unknown if ongoing. Concomitant medications included unspecified medications. The patient experienced pain through back across both arms and neck, the patient cannot lift their arms. The patient also experienced pain on both their legs cannot walk, a headache that feels like their heads going to explode, nauseated all the time, swell up like a balloon, chills and fever. It was reported that the events occurred on 21Jan2021. Therapeutic measures were taken as a result of pain through back across both arms and neck. The patient did not recover from the events.  Information on the lot/batch number has been requested.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Pain through back across both arms and neck.; A headache that feels like my heads going to explode.; swell up like a balloon; Nauseated; Chills; fever; Pain on both my legs cannot walk; Pain through back across both arms and neck. Cannot lift my arms; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on the right arm on 20Jan2021 16:00 at single dose for covid-19 immunization.  Medical history included atrial fibrillation from an unknown date and unknown if ongoing , hypersensitivity (Known allergies: Yes) from an unknown date and unknown if ongoing, covid-19 (if covid prior vaccination: Yes) from an unknown date and unknown if ongoing. Concomitant medications included unspecified medications. The patient experienced pain through back across both arms and neck, the patient cannot lift their arms. The patient also experienced pain on both their legs cannot walk, a headache that feels like their heads going to explode, nauseated all the time, swell up like a balloon, chills and fever. It was reported that the events occurred on 21Jan2021. Therapeutic measures were taken as a result of pain through back across both arms and neck. The patient did not recover from the events.  Information on the lot/batch number has been requested.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Urticaria
Clinical narrative: Hives and red rash on legs; Hives and red rash on legs; This is a spontaneous report from a contactable consumer. An 85-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3249, expiration date not reported), via an unspecified route of administration (right arm), on 20Jan2021 12:15 at a single dose for COVID-19 immunisation. Medical history included prinzmetal angina, hypothyroidism, and penicillin and sulfa allergies, all from an unknown date. Concomitant medication included diltiazem, estradiol, pantoprazole, and atorvastatin calcium (ATORVAS). On 22Jan2021, the patient had a reaction to her first dose of vaccination, and she was wondering if that would be a problem when she takes the second dose. The reaction she had was some hives and some red rash on her leg and it happened about 48 hours after she got the shot. The patient took Claritin pill and some Anti-Itch SavOn as treatment. Her second dose of vaccine was scheduled 15Feb2021. The patient was recovering from the events.
Sex: F
Vaccine: COVID19
Symptoms: Stress
Clinical narrative: stress; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient) via a Pfizer-sponsored program. A 62-year-old female patient received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 22Jan2021 at a single dose as vaccine. Medical history and concomitant medications were not reported. The patient experienced stress on an unspecified date. It was noted that she was unable to keep her 2nd dose appointment and she's having surgery before her second dose. She had the vaccine last Friday, 22Jan2021. Her 2nd dose would be on 12Feb2021 and she wanted to change it to 2/8 because she's scheduled for surgery on 11Feb2021. Could her appointment be changed? She has been trying to change the appointment for the past 4 hours. She called one number and they said it was not the correct number and they gave me another number. She told the person before what she wanted and needed to do and didn't listen either. The patient said thank you, had been very helpful and alleviated her stress right now. Now, she could relax. The outcome of the event was recovering.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Fever; Body aches; Nausea; Vomiting; Headache; This is a spontaneous report from a contactable nurse (patient).  A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration first dose on 28Dec2020 at single dose for covid-19 immunisation. The patient's medical history Covid-19 from Apr2020. The patient's concomitant medications were not reported. On an unspecified date, the patient would like to know if she should receive the second dose of the Pfizer COVID-19 vaccine after having an adverse reaction with her first dose of the COVID-19 vaccine. The patient experienced "fever, body aches, nausea, vomiting, headache, all that stuff and it lasted about 5 or 6 days. The patient had to miss work for a couple of days. The patient did not have any anaphylactic type reactions though. The outcome of the events was unknown.  Information about batch/lot number has been requested.